Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases

Objective. Gefitinib often induces liver damage. A few reports have described that the subsequent administration of erlotinib was associated with less hepatotoxicity, but the safety and efficacy of this treatment are still not fully investigated. Therefore, we evaluated retrospectively the patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yano, Yukihiro, Namba, Yoshinobu, Mori, Masahide, Nakazawa, Yukie, Nashi, Ayumi, Kagami, Shinichi, Niinaka, Manabu, Yoneda, Tsutomu, Kimura, Hiromi, Yamaguchi, Toshihiko, Yokota, Soichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437396/
https://www.ncbi.nlm.nih.gov/pubmed/26316933
http://dx.doi.org/10.1155/2012/354657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437396/
https://www.ncbi.nlm.nih.gov/pubmed/26316933
http://dx.doi.org/10.1155/2012/354657

Ejemplares similares